Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke

Journal of Neurochemistry

Volumn 116, Issue 1, 2011, Pages 122-131

  Lapchak, Paul A ^a   Schubert, David R ^b   Maher, Pamela A ^b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

drugs; ischemia; models; neuroprotection; protein kinases; trophic factor

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CNB 001; CURCUMIN; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPROTECTIVE AGENT; OXYGEN REGULATED PROTEIN 150; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; RAS PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; BEHAVIOR DISORDER; BRAIN ISCHEMIA; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME PHOSPHORYLATION; EXCITOTOXICITY; EXPERIMENTAL RABBIT; IN VITRO STUDY; MALE; MOTOR PERFORMANCE; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN ISCHEMIA; CELLS, CULTURED; CURCUMIN; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PYRAZOLES; RABBITS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

ORYCTOLAGUS CUNICULUS;

EID: 78650136403     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07090.x     Document Type: Article

References (41)

1. Cole G. M., Teter B., and, Frautschy S. A., (2007) Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 595, 197-212.
2. Davis J. B., and, Maher P., (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652, 169-173.
3. Dirnagl U., Iadecola C., and, Moskowitz M. A., (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
4. Dohare P., Garg P., Jain V., Nath C., and, Ray M., (2008) Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav. Brain Res. 193, 289-297.
5. Ferguson K. N., Kidwell C. S., Starkman S., and, Saver J. L., (2004) Hyperacute treatment initiation in neuroprotective agent stroke trials. J. Stroke Cerebrovasc. Dis. 13, 109-112.
6. Frautschy S. A., Hu W., Kim P., Miller S. A., Chu T., Harris-White M. E., and, Cole G. M., (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging 22, 993-1005.
7. Hacke W., Kaste M., Bluhmki E., et al. (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329.
8. Ingall T., (2004) Stroke-incidence, mortality, morbidity and risk. J. Insur. Med. 36, 143-152.
9. Lahair M. M., Howe C. J., Rodriguez-Mora O., McCubrey J. A., and, Franklin R. A., (2006) Molecular pathways leading to oxidative stress-induced phosphorylation of Akt. Antioxid. Redox Signal. 8, 1749-1756.
10. Lapchak P. A., (2010a) Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator. Brain Res. 1309, 136-145.
11. Lapchak P. A., (2010b) Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development. Trans. Stroke Res. 1, 96-107.
12. Lapchak P. A., and, Araujo D. M., (2007) Advances in ischemic stroke treatment: neuroprotective and combination therapies. Expert Opin. Emerg. Drugs 12, 97-112.
13. Lapchak P. A., and, De Taboada L., (2010) Transcranial near infrared laser treatment (NILT) increases cortical adenosine-5′-triphosphate (ATP) content following embolic strokes in rabbits. Brain Res. 1306, 100-105.
14. Lapchak P. A., Wei J., and, Zivin J. A., (2004) Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke 35, 1985-1988. (Pubitemid 38971888)
15. Lapchak P. A., Maher P., Schubert D., and, Zivin J. A., (2007) Baicalein, an antioxidant 12/15 lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes. Neuroscience 150, 585-591.
16. Li N., Wang C., Wu Y., Liu X., and, Cao X., (2009) Ca(2+)/calmodulin- dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and subsequently modulating p27 phosphorylation. J. Biol. Chem. 284, 3021-3027.
17. Liu Y., Dargusch R., Maher P., and, Schubert D., (2008) A broadly neuroprotective derivative of curcumin. J. Neurochem. 105 1336-1345 [Accepted for publication prior to April 1337, 2008].
18. Liu C., Wu J., Xu K., Cai F., Gu J., Ma L., and, Chen J., (2010) Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. J. Neurochem. 112, 1500-1512.
19. Lyden P., Lu M., Jackson C., Marler J., Kothari R., Brott T., and, Zivin J., (1999) Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke 30, 2347-2354.
20. Maher P., and, Davis J., (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 6394-6401.
21. Maher P., Salgado K. F., Zivin J. A., and, Lapchak P. A., (2007) A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res. 1173, 117-125. PMCID: PMC2111291.
22. Maher P., Akaishi T., Schubert D., and, Abe K., (2008) A pyrazole derivative of curcumin enhances memory. Neurobiol. Aging 31, 706-709. Not funded by NIH.
23. Mattson M. P., (2008) Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann. N Y Acad. Sci. 1144, 97-112.
24. Mehta S. L., Manhas N., and, Raghubir R., (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 54, 34-66.
25. Nakatani Y., Kaneto H., Kawamori D., et al. (2005) Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280, 847-851. Epub 2004 Oct. 2027. Erratum in: J. Biol. Chem. 2005 Aug 2026; 2280(2034):30648. (Pubitemid 40165054)
26. Rossler O. G., Giehl K. M., and, Thiel G., (2004) Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase. J. Neurochem. 88, 1240-1252.
27. Sanson M., Auge N., Vindis C., et al. (2009) Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression. Circ. Res. 104, 328-336.
28. Saver J. L., and, Gornbein J., (2009) Treatment effects for which shift or binary analyses are advantageous in acute stroke trials. Neurology 72, 1310-1315.
29. Schratt G. M., Nigh E. A., Chen W. G., Hu L., and, Greenberg M. E., (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 24, 7366-7377.
30. Schubert D., and, Piasecki D., (2001) Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 21, 7455-7462.
31. Sigalov E., Fridkin M., Brenneman D. E., and, Gozes I., (2000) VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury. J. Mol. Neurosci. 15, 147-154.
32. Tamatani M., Matsuyama T., Yamaguchi A., et al. (2001) ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat. Med. 7, 317-323.
33. Tan S., Schubert D., and, Maher P., (2001) Oxytosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497-506.
34. Taylor B. M., Fleming W. E., Benjamin C. W., Wu Y., Mathews W. R., and, Sun F. F., (1996) The mechanism of cytoprotective action of lazaroids I: inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J. Pharmacol. Exp. Ther. 276, 1224-1231.
35. Thiyagarajan M., and, Sharma S. S., (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 74, 969-985.
36. Vanlangenakker N., Vanden Berghe T., Krysko D. V., Festjens N., and, Vandenabeele P., (2008) Molecular mechanisms and pathophysiology of necrotic cell death. Curr. Mol. Med. 8, 207-220.
37. Waud D. R., (1972) On biological assays involving quantal responses. J. Pharmacol. Exp. Ther. 183, 577-607.
38. Wu A., Ying Z., and, Gomez-Pinilla F., (2006) Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp. Neurol. 197, 309-317.
39. Zhao H., Sapolsky R. M., and, Steinberg G. K., (2006) Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol. Neurobiol. 34, 249-270.
40. Zivin J. A., and, Waud D. R., (1992) Quantal bioassay and stroke. Stroke 23, 767-773.
41. Zivin J. A., Fisher M., DeGirolami U., Hemenway C. C., and, Stashak J. A., (1985) Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230, 1289-1292.